Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;24(1):233-240.
doi: 10.1016/j.drudis.2018.05.032. Epub 2018 May 28.

microRNAs and cardiac stem cells in heart development and disease

Bo Li  1 , Xianmei Meng  2 , Lubo Zhang  2
Affiliations
Review

microRNAs and cardiac stem cells in heart development and disease

Bo Li et al. Drug Discov Today. 2019 Jan.

Abstract

Cumulative evidence has proven that proliferation, differentiation and migration of cardiac stem cells (CSCs) dominate early heart development and contribute to the later occurrence of heart disease. Among other mechanisms, microRNAs work as the 'fine-tuning' to modulate the levels of target genes in a specific cell type. The distinct microRNA signatures in CSCs reveal the stages and functions of CSCs. The focus of this review is to summarize recent knowledge advances in CSC proliferation, differentiation and migration and to discuss how microRNAs regulate these processes during heart development and in heart disease. Better understanding of microRNA regulation on CSCs under different situations will enable the unveiling of the mechanisms of heart disease and open new avenues in the therapeutic potentials of microRNA modulation to treat heart disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors declare no conflicts of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
CSCs) in cardiac regeneration after myocardial injury. Resting endogenous CSCs are rapidly activated after myocardial injury. These activated CSCs proliferate speedily and migrate to the injured field to directly differentiate into functional cell lineages, including CMs, ECs and SMCs. Meanwhile, exogenous factors could further enhance the regenerative capacity of endogenous CSCs. For example, engrafted CSCs that are injected into the injured border zone promote differentiation of activated CSCs into trilineage cells via paracrine effects. All these processes contribute to the improvement of the heart function. Abbreviations: CSCs, cardiac stem cells; CMs, cardiomyocytes; SMCs, smooth muscle cells; ECs, endothelial cells.
Figure 2
Figure 2
Role of miRNAs in regulating CSC proliferation, differentiation and migration. (a) Various miRNAs regulate proliferation-related signaling pathways in CSCs. Several miRNAs, such as miR-21, miR-218, miR-548c, miR-509 and miR-23b, induce CSC proliferation by targeting negative regulators of cell proliferation, whereas miR-1, miR-200b and miR-204 inhibit CSC proliferation by modulating proliferation-related transcription factors. (b) Several miRNAs regulate CSC differentiation into CMs. miRNAs from the miR-322/-503 cluster (miR-499 as well as miR-708) promote CM commitment by suppressing the factors that inhibit cardiac differentiation. By contrast, miR-133 targets NELF-A, a nuclear factor promoting cardiogenesis. miR-218 and miR-142 inhibit CSC differentiation by modulating sFRP2, a negative regulator of proliferation, and cardiac transcription factor MEF2C, respectively. (c) miR-22 and miR-29 promote SMC commitment. Their targets, EVI1 and YY1, suppress the SMC marker gene expression and negatively regulate SMC transcription factors, respectively. (d) miR-206 and miR-21 have been shown to directly control migration of CSCs. Induction of CSC migration to injured heart could enhance cardiac regeneration. Abbreviations: ATF2, activating transcription factor 2; miRNAs, microRNAs; CSCs, cardiac stem cells; CMs, cardiomyocytes; SMC, smooth muscle cell; Celf1, CUG-binding protein Elav-like family member 1; EVI1, ecotropic virus integration site 1 protein homolog; GATA-4, GATA-binding protein 4; Hand 2, hand transcription factor 2; HDAC, histone deacetylase 4; MEF2C, myocyte enhancer factor 2C; NELF-A, negative elongation factor-A; PDCD4, programmed cell death 4; PTEN, phosphatase and tensin homolog; Rod1, regulator of differentiation 1; sFRP2, secreted frizzled-related protein 2; TIMP-3, tissue inhibitor of metalloproteinases-3; YY1, transcription factor Yin Yang 1.
Figure 2
Figure 2
Role of miRNAs in regulating CSC proliferation, differentiation and migration. (a) Various miRNAs regulate proliferation-related signaling pathways in CSCs. Several miRNAs, such as miR-21, miR-218, miR-548c, miR-509 and miR-23b, induce CSC proliferation by targeting negative regulators of cell proliferation, whereas miR-1, miR-200b and miR-204 inhibit CSC proliferation by modulating proliferation-related transcription factors. (b) Several miRNAs regulate CSC differentiation into CMs. miRNAs from the miR-322/-503 cluster (miR-499 as well as miR-708) promote CM commitment by suppressing the factors that inhibit cardiac differentiation. By contrast, miR-133 targets NELF-A, a nuclear factor promoting cardiogenesis. miR-218 and miR-142 inhibit CSC differentiation by modulating sFRP2, a negative regulator of proliferation, and cardiac transcription factor MEF2C, respectively. (c) miR-22 and miR-29 promote SMC commitment. Their targets, EVI1 and YY1, suppress the SMC marker gene expression and negatively regulate SMC transcription factors, respectively. (d) miR-206 and miR-21 have been shown to directly control migration of CSCs. Induction of CSC migration to injured heart could enhance cardiac regeneration. Abbreviations: ATF2, activating transcription factor 2; miRNAs, microRNAs; CSCs, cardiac stem cells; CMs, cardiomyocytes; SMC, smooth muscle cell; Celf1, CUG-binding protein Elav-like family member 1; EVI1, ecotropic virus integration site 1 protein homolog; GATA-4, GATA-binding protein 4; Hand 2, hand transcription factor 2; HDAC, histone deacetylase 4; MEF2C, myocyte enhancer factor 2C; NELF-A, negative elongation factor-A; PDCD4, programmed cell death 4; PTEN, phosphatase and tensin homolog; Rod1, regulator of differentiation 1; sFRP2, secreted frizzled-related protein 2; TIMP-3, tissue inhibitor of metalloproteinases-3; YY1, transcription factor Yin Yang 1.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Benjamin EJ, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603. - PMC - PubMed
    1. Vicinanza C, et al. Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification. Cell Death Differ. 2017;24:2101–2116. - PMC - PubMed
    1. Hatzistergos KE, et al. Stimulatory effects of mesenchymal stem cells on cKit+ cardiac stem cells are mediated by SDF1/CXCR4 and SCF/cKit signaling pathways. Circ. Res. 2016;119:921–930. - PMC - PubMed
    1. Renko O, et al. SDF1 gradient associates with the distribution of c-Kit+ cardiac cells in the heart. Sci. Rep. 2018;8:1160. - PMC - PubMed
    1. Yuan X, et al. Disruption of spatiotemporal hypoxic signaling causes congenital heart disease in mice. J. Clin. Invest. 2017;127:2235–2248. - PMC - PubMed

Publication types